Catalyst Pharmaceutical CPRX Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Catalyst Pharmaceutical’s reported figures.
Based on trailing twelve months.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's return on assets?
- Catalyst Pharmaceutical (CPRX) reported return on assets of 21.5% in Q1 2026.
- How has Catalyst Pharmaceutical's return on assets changed year-over-year?
- Catalyst Pharmaceutical's return on assets decreased by 15.2% year-over-year, from 25.4% to 21.5%.
- What is the long-term trend for Catalyst Pharmaceutical's return on assets?
- Over 5 years (2020 to 2025), Catalyst Pharmaceutical's return on assets has grown at a -14.9% compound annual growth rate (CAGR), from 49.2% to 21.9%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.